Abstract
Chimeric genes which fuse the mouse histone H2a gene and the mouse U1b gene were constructed and introduced into CHO cells by cotransfection. In the UH genes, the U1b gene promoter and the start of the Ulb gene were fused to the H2a gene in the 5′ untranslated region. In the HU genes, the U1b 3′ end was inserted into the 3′ untranslated region of the H2a gene replacing the normal histone 3′ end. Transcripts from the UH genes initiated at the start of the U1 gene and ended at the normal histone 3′ end. Transcripts from the HU chimeric genes did not end at the U1 3′ end but extended at least 80 nucleotides further and had heterogeneous 3′ ends. Placing both a U1 snRNA promoter and a U1 snRNA 3′ end around a histone coding region resulted in transcripts which initiate and terminate at the appropriate U1 ends. These results are consistent with previous reports that formation of the U1 3′ ends require U1 promoters, but indicate that the histone 3′ end can be formed on transcripts initiating at U1 promoters. The transcripts initiated at the U1 start site and ending at the histone 3′ end are present on polyribosomes and show proper posttranscriptional regulation.
RNA polymerase II transcribes a variety of genes, including the polyadenylated mRNAs, the non-polyadenylated histone mRNAs and the U series of small nuclear RNAs which contain 5′ trimethylated cap structures. These classes of transcripts have different 3′ ends. The polyadenylated mRNAs are formed by an endonucleolytic cleavage 15–30 nucleotides 3′ to an AAUAAA sequence, followed by polyadenylation (Birnstiel et al., 1985). A less highly conserved GU rich sequence located 3′ of the cleavage site is also required for efficient processing (Proudfoot, 1989). The histone 3′ ends are also formed by an endonucleolytic cleavage requiring a bipartite recognition sequence: a highly conserved stem-loop just 5′ to the cleavage site and a less highly conserved purine-rich sequence 3′ to the cleavage site, which binds the U7 snRNP (Birchmeier et al., 1984; Gick et al., 1986; Mowry and Steitz, 1987).
In contrast, formation of the 3′ ends of the snRNAs transcribed by RNA polymerase II requires that the polymerase initiate from an snRNA promoter (Hernandez and Weiner, 1986; Neuman de Vegvar et al., 1986). There is a relatively poorly conserved consensus sequence 3′ to the end of the primary transcript (Ach and Weiner, 1987) and no absolute requirement for sequences in the transcript for proper 3′ end formation (Hernandez and Weiner, 1986). If a herpes virus thymidine kinase, globin, or adenovirus promoter replaces the snRNA promoter, then the snRNA 3′ end is not formed (Hernandez and Weiner, 1986; Neuman de Vegvar et al., 1986), transcription continues past the normal site, and the transcripts are polyadenylated using cryptic or natural polyadenylation sites. In addition, longer read-through transcripts formed in isolated nuclei are not precursors to mature U1 RNA molecules (Lobo and Marzluff, 1987). Potential precursors to U1 snRNA are not processed when they are injected into Xenopus oocytes (Neuman de Vegvar et al., 1986; Dahl-berg and Lund, 1989). These results suggest that a sequence in the snRNA promoter is required for proper 3′ end formation which occurs co-transcriptionally, either as a termination event or a very rapid processing event.
There is also a report that transcripts which initiate at snRNA promoters do not utilize polyadenylation sites and do not form functional mRNAs (Dahlberg and Schenborn, 1988). Taken together, these results indicate that the synthetic machinery for the production of the polyadenylated mRNAs and snRNAs are separate. Since histone mRNAs, like U snRNAs, lack introns and are not polyadenylated, we have examined the expression of chimeric histone-snRNA transcripts. The snRNA promoter will direct formation of functional histone mRNAs. However, the histone mRNA promoter directs formation of transcripts which are not terminated/processed at the snRNA 3′ end but end heterogeneously 3′ of the normal 3′ end. However, if both the U1 promoter and U1 3′ end are attached to a histone coding region, defined transcripts initiating at the U1 start site and ending at the U1 3′ end are formed.
Materials and methods
Construction of cloned genes
The chimeric U1 and histone H2a genes were constructed from the mouse histone H2a.614 gene (Graves et al., 1985; Hurt et al., 1989) and the mouse Ulb.l and Ulb.2 genes (Marzluff et al., 1983; Moussa et al., 1987). A U1 deletion mutant with a minimal promoter containing 226 nucleotides of 5′ flanking sequence was digested with HphI (which cuts at nucleotide 50) or BstNl (which cuts at nucleotide 5) in the coding region, the ends blunted with the Klenow fragment of DNA polymerase and the fragment cloned into pUC18 to give the promoter cassettes, pUl5 and pUl50. Two U1 3′ ends with different amounts of coding region were cloned by digesting the Ulb.2 gene at nucleotide 156 with Cfol, blunting the end with T4 polymerase and releasing the 3′ end fragment with BglII. This fragment was inserted into pUC19 digested with BamHl and HincII to give pUl156. The Ulb.l gene was digested with TaqI at nucleotide 117 and the 130 nucleotide EcoRl to TaqI fragment was inserted into pUC18 digested with EcoRl and AccI to give pU117. The H2a.614 coding region plus the 3′ end was cloned by digestion of the EcoRl to Xbal fragment extending from −812 to 320 nucleotides past the end of the stem-loop with HphI which cuts at nucleotide −9 between the TATAA box and normal transcription start site. The end was blunted with the Klenow fragment of DNA polymerase, the histone coding region plus the 3′ end released by digestion with Xbal, and the fragment inserted into either pUl5 or pUl50 to give pUl5H and pUl50H respectively. The H2a.614 promoter plus coding region was cloned as an EcoRl-SstI subclone which ends 20 nucleotides before the 3′ stem-loop. This fragment was inserted into the pU156 and pU117 constructs to give pHU117 and pHU156− The histone promoter was replaced by the U1 promoter to make the UHU156 and UHU117 genes. The UHHU genes were constructed by adding either the U117 or U156 3′ end onto a complete histone gene. The structure of the genes is shown in Figures 1A and 1B, and the sequence across the junctions is shown in Figure 1C.
Transfection
The genes were introduced into CHO cells by cotransfection with the pSVneo gene using the polybrene procedure of Chaney et al. (1986). Stable transfectants were isolated by selection with G418 as previously described (Levine et al., 1988; Liu et al., 1989). Pools of transfectants, 20–50 per flask, were pooled and grown in the absence of G418 for analysis of expression of the transfected genes. One transfection, CHO-156C, yielded very few (<5) colonies.
Preparation and analysis of RNA
Total cell RNA was prepared from exponentially growing cells (<50% confluent) as previously described (Levine et al., 1988). In some experiments cells were fractionated into nuclear and cytoplasmic fractions. RNA was analyzed by S1 nuclease mapping using the genes 3′ labeled at the Narl site (at codon 45) or the AvaI site (at codon 20) of the H2a gene to map the 3′ end and labeled at the 5′ end of the NarI site or the Aval site to map the 5′ end. The conditions of hybridization and digestion have been described (Graves et al., 1985), and the temperature of hybridization was 58°C for all probes. The protected fragments were resolved by electrophoresis on 6% polyacrylamide-7M urea gels and detected by autoradiography.
Results
In order to test the compatibility of histone promoters and 3′ ends with the snRNA promoters and 3′ ends, we constructed the four chimeric genes with a U1 promoter or U1 3′ end replacing the histone promoter or 3′ end shown in Figure 1A. These genes all contain the intact mouse histone H2a-614 coding region, with either the U1 promoter or the U1 3′ end replacing the corresponding histone sequence. The U1 promoter sequence included either 5 or 50 nucleotides of the U1 coding region and was attached 9 nucleotides prior to the normal start of transcription of the H2a-614 gene. The U1 3′ end including the last 49 or 10 nucleotides of the coding region was attached in the H2a-614 3′ untranslated region in place of the normal stem-loop sequence.
In Figure 1B we show additional constructs which contain U1 promoters and U1 3′ ends. Two constructs (UHU117 and UHU156) had the U15 promoter and two different U1 3′ ends flanking the complete histone coding region. Finally in the UHHU117 and UHHU156 genes, the U15 promoter was followed by a histone H2a coding region and H2a 3′ end and then the U1 3′ end was placed 3′ of the histone 3′ end. The sequences at the junctions of the U1 and histone genes in the four chimeric transcripts are shown in Figure 1C.
These eight genes were introduced into CHO cells in low copy number by cotransfection with the neomycin resistance gene and stable trans-formants selected for resistance to G418. To analyze for expression of the genes we utilized SI nuclease assays, which allowed us to measure the 5′ and 3′ ends of the transcripts.
Transcripts which initiate at U1 promoters form histone 3′ ends
Figure 2 shows the expression of the U1-histone (UH) chimeric genes. Transfection of CHO cells by this procedure results in low copy number transfections which show levels of histone gene expression which reflect the activity of the genes in mouse cells (Levine et al., 1988). We have previously shown that the H2a-614 gene is expressed very efficiently in CHO cells (Levine et al., 1988). The 3′ SI nuclease assays show that large amounts of transcripts which end at the histone 3′ end accumulated in CHO cells transfected with the U5H or U50H gene (Fig. 2A). Similar amounts of transcripts (about 50% of the amount expressed from the H2a-164 gene), accumulated in the cells transfected with the U1/H2a chimeric genes as in the cells transfected with intact H2a-614 gene (Fig. 2A), indicating that the U1 promoter efficiently directed transcription of histone mRNA.
Figure 2B shows the 5′ ends of these transcripts mapped using the U50H or U5H genes labeled at the 5′ end of the Aval site located at codon 20 in the histone coding region. All of the transcripts from the U50H gene initiated at the U1 5′ end (Fig. 2B, lanes 1 and 2). Note that the same sample was analyzed in lanes 1 and 7. In the mapping in lane 7 all the transcripts from the U50H gene are mapped to the same site, the point of divergence from the U5H gene. Since the protected fragments in lane 1 and 7 are the same intensity relative to the endogenous histone mRNA, this indicates that there are not significant amounts of read-through transcripts which initiated upstream of the normal U1 start site. Similar results were found for the U5H gene (Fig. 2B, lanes 5 and 6). Again we can rule out the presence of read-through transcripts which originate upstream of the U1 start site by comparing the intensities of the bands in lanes 3 and 5, which are assays of the same RNA sample. RNA from cells transfected with the intact H2a–614 gene was also assayed (Fig. 2B, lanes 4 and 8), and these assays confirmed that the levels of expression of histone mRNAs from the U1 and histone promoters were similar. Since there were similar relative intensities obtained for both the 5′ and 3′ ends of the UH mRNAs and the H2a–614 mRNAs, we can conclude that the great majority of the transcripts which initiated at the U1 promoter went all the way to the histone 3′ end.
The UH mRNAs show proper posttranscriptional regulation
The U5H RNA should encode an authentic histone protein, since the first AUG in the transcript at position 71 is the same AUG codon which initiates translation of the H2a.2 protein, and the complete coding sequence is present. To determine whether transcripts which initiated at a U1 promoter formed functional mRNAs, the cells were fractionated into nuclear (Fig. 3A, lane N), polysomal (lane P) and cyto-solic (lane S) fractions. The U5H RNA fractionated in parallel with the endogenous histone mRNA and was predominantly present on polyribosomes, indicating that it is actively translated. In Figure 3A the U5H RNAs were mapped with the same 3′ labeled probe used in Figure 2A. The amount of U1 RNA in each fraction was monitored and over 90% of the U1 RNA was in the nuclear fraction (not shown).
One characteristic of the regulation of histone mRNAs is that the polysomal histone mRNAs are rapidly degraded when DNA synthesis is inhibited (Sittman et al., 1983; Graves et al., 1987). Figure 3B shows that the U5H RNA shows normal posttranscriptional regulation of histone mRNA degradation which is found for all histone genes (Marzluff and Pandey, 1988). To test whether the UH mRNAs were regulated coordinately with DNA synthesis, the transfected cells were treated with hydroxyurea and the UH RNAs mapped with a probe labeled at the 5′ end of the NarI site at codon 45 in the histone H2a gene. This probe maps the endogenous hamster histone mRNAs more efficiently than the probe labeled at codon 20 (cf. Fig. 3B with Fig. 2B). The UH mRNAs and the endogenous hamster mRNAs were rapidly degraded (Fig. 3B, lanes 2 and 4). This result indicates that the UH chimeric histone mRNAs show the normal posttranscriptional regulation. This result is consistent with the finding that the regulation of histone mRNA degradation requires only the stem-loop at the 3′ end of the histone mRNA (Graves et al., 1987; Pandey and Marzluff, 1987).
Transcripts initiating at a histone promoter do not form U1 3′ ends
Figure 4 shows the S1 mapping results with the histone/Ul (HU) chimeric genes. To show that transcripts were formed from these genes, S1 nuclease mapping was performed using the mouse histone H2a-614 gene as a probe (Fig. 4A). This probe maps all transcripts which extend at least 60 nucleotides past the end of the histone coding region as a single protected fragment, due to protection of the probe up to the point where the U1 sequence was attached. Clearly there were transcripts formed from the HU genes (Fig. 4A, band T). To attempt to map the ends of these transcripts we used an homologous probe (Fig. 4B). No major defined transcripts were detected using this probe, suggesting that the 3′ ends of these transcripts were heterogenous. In Figure 4C we used a probe which had additional polylinker sequences not in the transfected gene placed 80 nucleotides (UHU117) or 110 (UHU156) nucleotides 3′ of the U1 3′ end. These probes allow one to map all the transcripts which extend past the U1 end as a single protected fragment of about 450 nucleotides (RT in Fig. 4C). Figure 4C shows that transcripts extending at least 90 nucleotides past the U1 3′ end are readily detected, demonstrating that the U1 3′ end is not used by transcripts which have initiated at a histone promoter. Thus transcripts which initiate at a histone promoter do not form U1 3′ ends.
Placing a U1 promoter on the HU gene restores U1 3′ end formation
Two additional genes, UHU117 and UHU156, were constructed which had the U1 promoter and 5 nucleotides of the U1 coding region replacing the histone promoter (see Fig. 1B). These genes were transfected into CHO cells and the transcripts assayed by S1 nuclease mapping using an homologous probe. Figure 5A shows that there were transcripts formed ending at the U1 3′ end from both of the UHU genes. To estimate the efficiency of U1 3′ end formation, these RNAs were also mapped using the probes used in Figure 4C, which can map any read-through transcripts which extend past the U1 3′ end. Any transcripts extending past the U1 3′ end will be detected as a single protected fragment, as discussed above (RT in Fig. 5B). Figure 5B shows that about 50 % of the transcripts from both the UHU117 and UHU156 genes present in steady-state RNA had U1 3′ ends and about 50% of the transcripts were at least 80 nucleotides longer than the U1 RNA and ended heterogeneously.
The great majority of these transcripts present in steady-state RNA were initiated at the U1 start site. Figure 5C shows the results of S1 nuclease mapping of the 5′ end of the transcripts from the same RNAs analyzed in Figure 5B. As was found for the UH genes, most – if not all – of the transcripts initiated at the U1 start site (Fig. 5C, lanes 1 and 2; see also Fig. 5D, lane 7). Similar results have been found in four independent transfections of each UHU gene, each transfection yielding a pool of more than 30 transformants.
Figure 5D shows an example of a transfection, CHO-156C, in which the UHU156 gene was expressed in an unusual manner. In the CHO-156C transfection, there were less than 5 colonies obtained, and it is possible that all of the colonies were derived from a single transfectant. The 3′ ends of the transcripts were mapped using two probes, the UHU117 gene (Fig. 5D, lanes 1–3) and the homologous UHU156 gene (Fig. 5D, lane 5). The UHU117 probe will map the transcripts ending at the U1 end from the UHU117 genes (Fig. 5D, lanes 1 and 2) and will map all transcripts from the UHU156 gene which extend past the histone coding region as a single fragment of 322 nucleotides, the point where the UHU117 and UHU156 gene diverge (Fig. 5D, lane 3). There were large amounts of transcripts formed in the CHO-156C cells (Fig. 5D, lane 3), but very few, if any, of these transcripts ended at the U1 3′ end when they were mapped with an homologous probe (Fig. 5D, lane 5), suggesting that the 3′ ends are heterogenous and/or extend past the end of the probe. When the 5′ ends of these transcripts were mapped using a probe labeled at the 5′ end of the NarI site at codon 45 of the H2a gene, most of the transcripts from the UHU156 gene in these cells initiated upstream of the U1 start site (Fig. 5D, lane 6, band U1RT). In contrast, in all the other transfections at least 90% of the transcripts initiated at the U1 start site, although there were a small number of transcripts which initiated at the upstream start site (Fig. 5D, lane 7). It is likely that these read-through transcripts are a result of the transfected gene integrating 3′ of a strong promoter. Thus in the CHO-156C cells, transcripts which initiated upstream of the U1 gene and traversed the entire U1 promoter and gene did not form U1 3′ ends.
Although replacing the histone promoter and 3′ end with a U1 3′ end and U1 promoter on a histone gene restored formation of U1 3′ ends, the U1 3′ end was not dominant to a histone 3′ end. The UHHU genes (see Fig. 1B) had both a histone 3′ end and U1 3′ end. The 3′ ends were mapped with the UHU156 gene, which maps all transcripts from these genes (Fig. 6, lanes 1 and 2, band T), and with the appropriate homologous probe (Fig. 6, lanes 3 and 4). All the transcripts from these genes had histone 3′ ends (Fig. 6, lanes 3 and 4). We would have detected transcripts ending at the U1 3′ end if they had been present in 5% of the amount of the histone transcripts. Identical results were obtained with the UHHU156 (Fig. 6, lanes 3 and 6) and UHHU117 (Fig. 6, lanes 4 and 5) genes. The 5′ ends of these transcripts were mapped and all the transcripts initiated at the normal U1 start site (Fig. 6, lanes 5 and 6). The presence of the histone 3′ end probably did not prevent transcription continuing to the U1 3′ end, since transcription normally extends several hundred nucleotides 3′ of the histone genes (Chodchoy et al., 1987; Chodchoy et al., 1991). It is likely that the histone 3′ ends are formed rapidly and efficiently on transcripts which initiate at a U1 promoter. However, we cannot rule out the possibility that the initial transcripts formed had U1 3′ ends, which were then further processed to yield histone 3′ ends.
Discussion
The results reported here extend the previous reports that the formation of snRNA 3′ ends is dependent on proper initiation from an snRNA promoter (Hernandez and Weiner, 1986; Neuman de Vegvar et al., 1986). They also demonstrate that initiation from a U1 promoter is compatible with formation of histone 3′ ends, and that functional histone mRNA is produced from the UH genes. In addition, we show that transcripts initiated from a histone promoter do not form U1 3′ ends, although placing a U1 promoter and U1 3′ end signal around a histone gene lacking a histone 3′ end results in defined transcripts which start and end at the proper U1 termini.
The coupling of the promoter to 3′ end formation is a unique property of the snRNA genes. Histone genes share some common features with U snRNA genes in that they do not contain introns and do not encode polyadenylated RNAs. Transcripts which initiate from histone promoters do not form U1 3′ ends; instead, the transcripts extend past the U1 3′ end and end heterogeneously. However, histone 3′ ends are formed efficiently on transcripts which initiate from a globin promoter (Whitelaw et al., 1986; Pandey et al., 1990), and polyadenylated RNAs are formed efficiently when a histone promoter drives a gene containing a polyadenylation signal (Levine et al., 1987).
In contrast, the initiation of transcription from a U1 snRNA promoter is compatible with the formation of histone 3′ ends. The amount of histone mRNA formed from the UH genes is similar to the amount of RNA which accumulates from the intact histone H2a-614 gene. Since both of these promoters are highly active promoters, it is likely that most, if not all, of the transcripts which initiate at the U1 promoter form histone 3′ ends. The U5 Hgene also gives rise to a functional histone mRNA which is present on polyribosomes. The first AUG codon in this transcript is the AUG codon in the H2a gene, and the rest of the sequence is identical to the H2a-614 mRNA. The U5H RNA is rapidly degraded when DNA synthesis is inhibited, as is the endogenous histone mRNA. This is expected since the 3′ end of histone mRNA is responsible for the posttranscriptional regulation of histone mRNA levels (Luscher and Schümperli, 1987; Graves et al., 1987; Pandey and Marzluff, 1987).
These results are in contrast to the results of Dahlberg and Schenborn, who did not observe any functional polyadenylated mRNA from a chloramphenicol acetyltransferase (CAT) gene driven by a U1 promoter (Dahlberg and Schenborn, 1988). This was probably at least partially due to premature termination of the transcript due to presence of cryptic 3′ end signals in the CAT gene, which “terminated” transcripts which initiated at the U1 promoter (Dahlberg and Schenborn, 1988). The signals required for 3′ end formation on transcripts initiated at a U1 promoter are rather flexible (Ach and Weiner, 1987). The histone H2a-614 gene is over 70% GC in the coding region (Hurt et al., 1989) and does not contain any cryptic “termination” sites. Transcripts initiated at the U1 promoter efficiently transcribe the complete histone coding region and form large amounts of histone mRNA.
There is also a report that transcripts which initiate at a U1 promoter do not efficiently utilize 3′ polyadenylation sites (Neuman de Vegvar et al., 1986), although other workers have shown that in some instances transcripts initiating at U1 snRNA promoters could be polyadenylated (Hernandez and Weiner, 1986). These results differ from our results, which show that the histone 3′ processing signals are efficiently used on transcripts which initiate from a U1 promoter. It is clear from these results that there is no intrinsic block to the formation of long transcripts from the U1 promoter. We infer that the utilization of the histone 3′ signals is very efficient, since placing a U1 3′ end only 60 nucleotides 3′ of the histone 3′ end (in the UHHU156 gene) did not result in accumulation of any transcripts ending at the U1 3′ end.
These results do not allow us to determine the mechanism of coupling of the U1 promoter to 3′ end formation. There are two likely possibilities: either the promoter determines a specific transcription termination site which is not recognized by RNA polymerase II which has initiated at other promoters; or, alternatively, there is a processing factor which associates with the transcription complex initiating from an snRNA promoter, and processing is tightly coupled with transcription. Clearly the two characterized processing reactions which form the 3′ ends of mRNAs, cleavage of the pre-histone mRNA, or cleavage and polyadenylation of other mRNAs, are posttranscriptional. Thus, if the U1 snRNA 3′ ends are formed by processing, it must involve a novel co-transcriptional processing mechanism.
Acknowledgments
This work was supported by grants GM 27789 and GM 29832 from the NIH to W. F. M.
The costs of publishing this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 USC Section 1734 solely to indicate this fact.
Duane R. Pilch is currently at the National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
References
- Ach R. A. and Weiner A. M. (1987), Mol Cell Biol 7, 2070–2079. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Birchmeier C., Schümperli D., Sconzo G., and Birnstiel M. L. (1984), Proc Nad Acad Sci USA 81, 1057–1061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Birnstiel M. L., Busslinger M., and Strub K. (1985), Cell 41, 349–359. [DOI] [PubMed] [Google Scholar]
- Chaney W. G., Howard D. R., Pollard J. W., Sallustio S., and Stanley P. (1986), Somatic Cell Mol Genet 12, 237–244. [DOI] [PubMed] [Google Scholar]
- Chodchoy N., Levine B. J., Sprecher C., Skoultchi A. I., and Marzluff W. F. (1987), Mol Cell Biol 7, 1039–1047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chodchoy N., Pandey N. B., and Marzluff W. F. (1991), Mol Cell Biol 11, 497–509. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dahlberg J. E. and Lund E. (1989), in Structure and Function of Major and Minor Small Nuclear Ribonucleoprotein Particles (Birnstiel M. L., ed.), Springer-Verlag, Berlin, pp. 38–70. [Google Scholar]
- Dahlberg J. E. and Schenborn E. T. (1988), Nucl Acids Res 16, 5827–5840. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gick O., Krämer A., Keller W., and Birnstiel M. L. (1986), EMBO J 5, 1319–1326. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Graves R. A., Wellman S. E., Chiu I. M., and Marzluff W. F. (1985), J Mol Biol 183, 179–194. [DOI] [PubMed] [Google Scholar]
- Graves R. A., Pandey N. B., Chodchoy N., and Marzluff W. F. (1987), Cell 48, 615–626. [DOI] [PubMed] [Google Scholar]
- Hernandez N. and Weiner A. M. (1986), Cell 47, 249–258. [DOI] [PubMed] [Google Scholar]
- Hurt M. M., Chodchoy N., and Marzluff W. F. (1989), Nucl Acids Res 17, 8876. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Levine B. J., Chodchoy N., Marzluff W. F., and Skoultchi A. I. (1987) Proc Natl Acad Sci USA 84, 6189–6193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Levine B.J., Liu T. J., Marzluff W. F., and Skoultchi A. I. (1988), Mol Cell Biol 8, 1887–1895. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu T. J., Levine B. J., Skoultchi A. I., and Marzluff W. F. (1989), Mol Cell Biol 9, 3499–3508. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lobo S. M. and Marzluff W. F. (1987), Mol Cell Biol 7, 4290–4296. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lüscher B. and Schümperli D. (1987), EMBO J 6, 1721–1726. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marzluff W. F., Brown D. T., Lobo S., and Wang S. S. (1983), Nucl Acids Res 11, 6255–6270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marzluff W. F. and Pandey N. B. (1988), TIBS 13, 49–52. [DOI] [PubMed] [Google Scholar]
- Moussa N. M., E-L-Din A. S., Lobo S. M., and Marzluff W. F. (1987), Nucl Acids Res 15, 3622. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mowry K. L. and Steitz J. A. (1987), Mol Cell Biol 7, 1663–1672. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Neuman de Vegvar H. E., Lund E., and Dahlberg J. E. (1986), Cell 47, 259–266. [DOI] [PubMed] [Google Scholar]
- Pandey N. B. and Marzluff W. F. (1987), Mol Cell Biol 7, 4557–4559. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pandey N. B., Chodchoy N., Liu T.-J., and Marzluff W. F. (1990), Nucl Acids Res 18, 3161–3170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Proudfoot N. J. (1989), TIBS 14, 105–110. [DOI] [PubMed] [Google Scholar]
- Sittman D. B., Graves R. A., and Marzluff W. F. (1983), Proc Natl Acad Sci USA 80, 1849–1853. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Whitelaw E., Coates A., and Proudfoot N. J. (1986), Nucl Acids Res 14, 7059–7070. [DOI] [PMC free article] [PubMed] [Google Scholar]